Roche Pegasys Hep C Monotherapy Launch Expected Before Combo Approval
Roche Pegasys hepatitis C monotherapy could launch as early as October, two months before the expected approval of the combination pegylated interferon alfa-2a/ribavirin product
Roche Pegasys hepatitis C monotherapy could launch as early as October, two months before the expected approval of the combination pegylated interferon alfa-2a/ribavirin product